A 0 1 0 1 O
proteasome 2 12 2 12 B-treatment
inhibitor 13 22 13 22 I-treatment
and 23 26 23 26 O
Immunomodulatory 27 43 27 43 B-treatment
imide 44 49 44 49 I-treatment
drugs 50 55 50 55 I-treatment
( 56 57 56 57 I-treatment
IMiD 57 61 57 61 I-treatment
) 61 62 61 62 I-treatment

Absolute 0 8 63 71 B-clinical_variable
neutrophil 9 19 72 82 I-clinical_variable
count 20 25 83 88 I-clinical_variable
( 26 27 89 90 I-clinical_variable
ANC 27 30 90 93 I-clinical_variable
) 30 31 93 94 I-clinical_variable
≥ 32 33 95 96 O
1000 34 38 97 101 B-lower_bound
cells 39 44 102 107 I-lower_bound
/ 44 45 107 108 I-lower_bound
μl 45 47 108 110 I-lower_bound
( 48 49 111 112 O
growth 49 55 112 118 O
factor 56 62 119 125 O
can 63 66 126 129 O
not 66 69 129 132 O
be 70 72 133 135 O
used 73 77 136 140 O
within 78 84 141 147 O
the 85 88 148 151 O
previous 89 97 152 160 B-upper_bound
5 98 99 161 162 I-upper_bound
days 100 104 163 167 I-upper_bound
) 104 105 167 168 O

Any 0 3 169 172 O
> 4 5 173 174 O
grade 6 11 175 180 B-lower_bound
1 12 13 181 182 I-lower_bound
( 14 15 183 184 O
according 15 24 184 193 O
to 25 27 194 196 O
the 28 31 197 200 O
National 32 40 201 209 O
Cancer 41 47 210 216 O
Institute 48 57 217 226 O
Common 58 64 227 233 O
Terminology 65 76 234 245 O
Criteria 77 85 246 254 O
for 86 89 255 258 O
Adverse 90 97 259 266 O
Events 98 104 267 273 O
( 105 106 274 275 O
NCI 106 109 275 278 O
CTC 110 113 279 282 O
AE 114 116 283 285 O
) 116 117 285 286 O
v.4.03 118 124 287 293 O
) 124 125 293 294 O
adverse 126 133 295 302 O
reaction 134 142 303 311 O
unresolved 143 153 312 322 O
from 154 158 323 327 O
previous 159 167 328 336 O
treatments 168 178 337 347 B-treatment
or 179 181 348 350 O
not 182 185 351 354 O
readily 186 193 355 362 O
managed 194 201 363 370 O
and 202 205 371 374 O
controlled 206 216 375 385 O
with 217 221 386 390 O
supportive 222 232 391 401 O
care 233 237 402 406 O

Aspartate 0 9 407 416 B-clinical_variable
aminotransferase 10 26 417 433 I-clinical_variable
( 27 28 434 435 I-clinical_variable
AST 28 31 435 438 I-clinical_variable
/ 31 32 438 439 I-clinical_variable
SGOT 32 36 439 443 I-clinical_variable
) 36 37 443 444 I-clinical_variable
and 38 41 445 448 O
Alanine 42 49 449 456 B-clinical_variable
aminotransferase 50 66 457 473 I-clinical_variable
( 67 68 474 475 I-clinical_variable
ALT 68 71 475 478 I-clinical_variable
/ 71 72 478 479 I-clinical_variable
SGPT 72 76 479 483 I-clinical_variable
) 76 77 483 484 I-clinical_variable
≤ 78 79 485 486 O
3.0 80 83 487 490 B-upper_bound
x 84 85 491 492 I-upper_bound
upper 86 91 493 498 I-upper_bound
limit 92 97 499 504 I-upper_bound
of 98 100 505 507 I-upper_bound
normal 101 107 508 514 I-upper_bound
( 108 109 515 516 I-upper_bound
ULN 109 112 516 519 I-upper_bound
) 112 113 519 520 I-upper_bound

Clinically 0 10 521 531 O
significant 11 22 532 543 O
cardiovascular 23 37 544 558 B-chronic_disease
disease 38 45 559 566 I-chronic_disease
( 46 47 567 568 O
e.g. 47 51 568 572 O
, 51 52 572 573 O
uncontrolled 53 65 574 586 O
or 66 68 587 589 O
any 69 72 590 593 O
New 73 76 594 597 B-chronic_disease
York 77 81 598 602 I-chronic_disease
Heart 82 87 603 608 I-chronic_disease
Association 88 99 609 620 I-chronic_disease
( 100 101 621 622 I-chronic_disease
NYHA 101 105 622 626 I-chronic_disease
) 105 106 626 627 I-chronic_disease
Class 107 112 628 633 I-chronic_disease
3 113 114 634 635 I-chronic_disease
or 115 117 636 638 I-chronic_disease
4 118 119 639 640 I-chronic_disease
, 119 120 640 641 O
congestive 121 131 642 652 B-chronic_disease
heart 132 137 653 658 I-chronic_disease
failure 138 145 659 666 I-chronic_disease
, 145 146 666 667 O
uncontrolled 147 159 668 680 O
or 160 162 681 683 O
unstable 163 171 684 692 B-chronic_disease
angina 172 178 693 699 I-chronic_disease
, 178 179 699 700 O
history 180 187 701 708 O
of 188 190 709 711 O
myocardial 191 201 712 722 B-chronic_disease
infarction 202 212 723 733 I-chronic_disease
or 213 215 734 736 O
stroke 216 222 737 743 B-chronic_disease
within 223 229 744 750 O
6 230 231 751 752 B-upper_bound
months 232 238 753 759 I-upper_bound
prior 239 244 760 765 I-upper_bound
to 245 247 766 768 O
study 248 253 769 774 O
entry 254 259 775 780 O
, 259 260 780 781 O
or 261 263 782 784 O
clinically 264 274 785 795 O
significant 275 286 796 807 O
arrhythmias 287 298 808 819 B-chronic_disease
not 299 302 820 823 O
controlled 303 313 824 834 O
by 314 316 835 837 O
medication 317 327 838 848 O

Creatinine 0 10 849 859 B-clinical_variable
clearance 11 20 860 869 I-clinical_variable
≥ 21 22 870 871 O
30 23 25 872 874 B-lower_bound
ml 26 28 875 877 I-lower_bound
/ 28 29 877 878 I-lower_bound
min 29 32 878 881 I-lower_bound
( 33 34 882 883 O
calculated 34 44 883 893 O
by 45 47 894 896 O
the 48 51 897 900 O
Cockcroft 52 61 901 910 O
- 61 62 910 911 O
Gault 62 67 911 916 O
Equation 68 76 917 925 O
or 77 79 926 928 O
per 80 83 929 932 O
24 84 86 933 935 O
hour 87 91 936 940 O
urine 92 97 941 946 O
collection 98 108 947 957 O
) 108 109 957 958 O

Exclusively 0 11 959 970 O
or 12 14 971 973 O
primarily 15 24 974 983 O
eliminated 25 35 984 994 O
by 36 38 995 997 O
cytochrome 39 49 998 1008 B-clinical_variable
P-450 50 55 1009 1014 I-clinical_variable
isozyme 56 63 1015 1022 I-clinical_variable
3A4 64 67 1023 1026 I-clinical_variable
( 68 69 1027 1028 I-clinical_variable
CYP3A4 69 75 1028 1034 I-clinical_variable
) 75 76 1034 1035 I-clinical_variable

Females 0 7 1036 1043 B-gender
of 8 10 1044 1046 O
childbearing 11 23 1047 1059 O
potential 24 33 1060 1069 O
( 34 35 1070 1071 O
FCBP 35 39 1071 1075 O
) 39 40 1075 1076 O
must 41 45 1077 1081 O
have 46 50 1082 1086 O
a 51 52 1087 1088 O
negative 53 61 1089 1097 B-pregnancy
serum 62 67 1098 1103 I-pregnancy
or 68 70 1104 1106 I-pregnancy
urine 71 76 1107 1112 I-pregnancy
pregnancy 77 86 1113 1122 I-pregnancy
test 87 91 1123 1127 O
prior 92 97 1128 1133 O
to 98 100 1134 1136 O
initiation 101 111 1137 1147 O
of 112 114 1148 1150 O
the 115 118 1151 1154 O
study 119 124 1155 1160 O
treatment 125 134 1161 1170 B-treatment
with 135 139 1171 1175 O
TEW-7197 140 148 1176 1184 B-treatment
/POM 149 153 1185 1189 I-treatment

Hypertension 0 12 1190 1202 B-chronic_disease
that 13 17 1203 1207 O
is 18 20 1208 1210 O
not 21 24 1211 1214 O
controlled 25 35 1215 1225 O
by 36 38 1226 1228 O
standard 39 47 1229 1237 O
medication 48 58 1238 1248 O
( 59 60 1249 1250 O
to 60 62 1250 1252 O
150/90 63 69 1253 1259 B-upper_bound
mmHg 70 74 1260 1264 I-upper_bound
or 75 77 1265 1267 O
below 78 83 1268 1273 O
) 83 84 1273 1274 O

Inability 0 9 1275 1284 O
to 10 12 1285 1287 O
tolerate 13 21 1288 1296 O
thromboprophylaxis 22 40 1297 1315 B-chronic_disease
( 41 42 1316 1317 O
Required 42 50 1317 1325 O
Concurrent 51 61 1326 1336 B-treatment
Medications 62 73 1337 1348 I-treatment
) 73 74 1348 1349 O

Major 0 5 1350 1355 O
abnormalities 6 19 1356 1369 O
identified 20 30 1370 1380 O
by 31 33 1381 1383 O
ECG 34 37 1384 1387 B-treatment
or 38 40 1388 1390 I-treatment
echocardiogram 41 55 1391 1405 I-treatment
( 56 57 1406 1407 I-treatment
ECHO 57 61 1407 1411 I-treatment
) 61 62 1411 1412 I-treatment
, 62 63 1412 1413 O
at 64 66 1414 1416 O
the 67 70 1417 1420 O
Investigator 71 83 1421 1433 O
's 83 85 1433 1435 O
discretion 86 96 1436 1446 O

Men 0 3 1447 1450 B-gender
must 4 8 1451 1455 B-contraception_consent
agree 9 14 1456 1461 I-contraception_consent
to 15 17 1462 1464 I-contraception_consent
use 18 21 1465 1468 I-contraception_consent
a 22 23 1469 1470 I-contraception_consent
latex 24 29 1471 1476 I-contraception_consent
or 30 32 1477 1479 I-contraception_consent
synthetic 33 42 1480 1489 I-contraception_consent
condom 43 49 1490 1496 I-contraception_consent
during 50 56 1497 1503 O
sexual 57 63 1504 1510 O
contact 64 71 1511 1518 O
with 72 76 1519 1523 O
a 77 78 1524 1525 O
FCBP 79 83 1526 1530 O
even 84 88 1531 1535 O
if 89 91 1536 1538 O
they 92 96 1539 1543 O
have 97 101 1544 1548 O
had 102 105 1549 1552 O
a 106 107 1553 1554 O
vasectomy 108 117 1555 1564 B-treatment
from 118 122 1565 1569 O
the 123 126 1570 1573 O
time 127 131 1574 1578 O
of 132 134 1579 1581 O
signing 135 142 1582 1589 O
the 143 146 1590 1593 O
informed 147 155 1594 1602 O
consent 156 163 1603 1610 O
form 164 168 1611 1615 O
through 169 176 1616 1623 O
60 177 179 1624 1626 O
days 180 184 1627 1631 O
after 185 190 1632 1637 O
the 191 194 1638 1641 O
last 195 199 1642 1646 O
dose 200 204 1647 1651 O
of 205 207 1652 1654 O
POM 208 211 1655 1658 B-treatment
or 212 214 1659 1661 O
TEW-7197 215 223 1662 1670 B-treatment

No 0 2 1671 1673 O
oral 3 7 1674 1678 B-treatment
corticosteroids 8 23 1679 1694 I-treatment
3 24 25 1695 1696 O
days 26 30 1697 1701 O
before 31 37 1702 1708 O
initiating 38 48 1709 1719 O
combinations 49 61 1720 1732 O
TEW-7197 62 70 1733 1741 B-treatment
/ 70 71 1741 1742 I-treatment
POM 71 74 1742 1745 I-treatment

Patient 0 7 1746 1753 O
has 8 11 1754 1757 O
been 12 16 1758 1762 O
previously 17 27 1763 1773 O
diagnosed 28 37 1774 1783 O
with 38 42 1784 1788 O
multiple 43 51 1789 1797 B-cancer
myeloma 52 59 1798 1805 I-cancer
based 60 65 1806 1811 O
on 66 68 1812 1814 O
standard 69 77 1815 1823 O
criteria 78 86 1824 1832 O

Patient 0 7 1833 1840 O
is 8 10 1841 1843 O
known 11 16 1844 1849 O
to 17 19 1850 1852 O
be 20 22 1853 1855 O
human 23 28 1856 1861 B-chronic_disease
immunodeficiency 29 45 1862 1878 I-chronic_disease
virus 46 51 1879 1884 I-chronic_disease
( 52 53 1885 1886 I-chronic_disease
HIV 53 56 1886 1889 I-chronic_disease
) 56 57 1889 1890 I-chronic_disease
positive 58 66 1891 1899 O
, 66 67 1899 1900 O
or 68 70 1901 1903 O
have 71 75 1904 1908 O
chronic 76 83 1909 1916 O
or 84 86 1917 1919 O
active 87 93 1920 1926 O
Hepatitis 94 103 1927 1936 B-chronic_disease
B 104 105 1937 1938 I-chronic_disease
( 106 107 1939 1940 O
core- 107 112 1940 1945 O
or 113 115 1946 1948 O
surface 116 123 1949 1956 O
antigen 124 131 1957 1964 O
- 131 132 1964 1965 O
positive 132 140 1965 1973 O
) 140 141 1973 1974 O
or 142 144 1975 1977 O
active 145 151 1978 1984 O
hepatitis 152 161 1985 1994 B-chronic_disease
C 162 163 1995 1996 I-chronic_disease
infection 164 173 1997 2006 I-chronic_disease

Patients 0 8 2007 2015 O
requiring 9 18 2016 2025 O
hemodialysis 19 31 2026 2038 B-treatment

Patients 0 8 2039 2047 O
should 9 15 2048 2054 O
have 16 20 2055 2059 O
discontinued 21 33 2060 2072 O
strong 34 40 2073 2079 O
CYP1A2 41 47 2080 2086 B-treatment
inhibitors 48 58 2087 2097 I-treatment
( 59 60 2098 2099 O
e.g. 60 64 2099 2103 O
ciprofloxacin 65 78 2104 2117 B-treatment
and 79 82 2118 2121 O
fluvoxamine 83 94 2122 2133 B-treatment
) 94 95 2133 2134 O
at 96 98 2135 2137 O
least 99 104 2138 2143 O
five 105 109 2144 2148 B-lower_bound
half 110 114 2149 2153 O
- 114 115 2153 2154 O
lives 115 120 2154 2159 O
before 121 127 2160 2166 O
beginning 128 137 2167 2176 O
study 138 143 2177 2182 O
treatment 144 153 2183 2192 O

Patients 0 8 2193 2201 O
who 9 12 2202 2205 O
are 13 16 2206 2209 O
primarily 17 26 2210 2219 O
eligible 27 35 2220 2228 O
for 36 39 2229 2232 O
autologous 40 50 2233 2243 B-treatment
stem 51 55 2244 2248 I-treatment
cell 56 60 2249 2253 I-treatment
transplant 61 71 2254 2264 I-treatment

Plasma 0 6 2265 2271 B-cancer
Cell 7 11 2272 2276 I-cancer
Leukemia 12 20 2277 2285 I-cancer

Presence 0 8 2286 2294 O
of 9 11 2295 2297 O
aneurisms 12 21 2298 2307 B-chronic_disease
of 22 24 2308 2310 O
the 25 28 2311 2314 O
ascending 29 38 2315 2324 O
aorta 39 44 2325 2330 O
or 45 47 2331 2333 O
aortic 48 54 2334 2340 O
stress 55 61 2341 2347 O

Prior 0 5 2348 2353 B-treatment
anti 6 10 2354 2358 I-treatment
- 10 11 2358 2359 I-treatment
cancer 11 17 2359 2365 I-treatment
therapy 18 25 2366 2373 I-treatment
( 26 27 2374 2375 O
chemotherapy 27 39 2375 2387 B-treatment
, 39 40 2387 2388 O
targeted 41 49 2389 2397 B-treatment
agents 50 56 2398 2404 O
, 56 57 2404 2405 O
radiotherapy 58 70 2406 2418 B-treatment
, 70 71 2418 2419 O
and 72 75 2420 2423 O
immunotherapy 76 89 2424 2437 B-treatment
) 89 90 2437 2438 O
within 91 97 2439 2445 O
the 98 101 2446 2449 O
prior 102 107 2450 2455 B-upper_bound
21 108 110 2456 2458 I-upper_bound
days 111 115 2459 2463 I-upper_bound
except 116 122 2464 2470 O
for 123 126 2471 2474 O
alkylating 127 137 2475 2485 B-treatment
agents 138 144 2486 2492 I-treatment
( 145 146 2493 2494 O
e.g. 146 150 2494 2498 O
, 150 151 2498 2499 O
melphalan 152 161 2500 2509 B-treatment
) 161 162 2509 2510 O
within 163 169 2511 2517 O
the 170 173 2518 2521 O
prior 174 179 2522 2527 B-upper_bound
28 180 182 2528 2530 I-upper_bound
days 183 187 2531 2535 I-upper_bound

Prior 0 5 2536 2541 O
treatment 6 15 2542 2551 O
with 16 20 2552 2556 O
pomalidomide 21 33 2557 2569 B-treatment

Serum 0 5 2570 2575 B-clinical_variable
M 6 7 2576 2577 I-clinical_variable
protein 8 15 2578 2585 I-clinical_variable
≥ 16 17 2586 2587 O
0.5 18 21 2588 2591 B-lower_bound
/dL 22 25 2592 2595 I-lower_bound
( 26 27 2596 2597 O
≥5 27 29 2597 2599 O
g 30 31 2600 2601 I-lower_bound
/ 31 32 2601 2602 I-lower_bound
L 32 33 2602 2603 I-lower_bound
) 33 34 2603 2604 O

Serum 0 5 2605 2610 O
total 6 11 2611 2616 O
bilirubin 12 21 2617 2626 B-clinical_variable
≤ 22 23 2627 2628 O
2.0 24 27 2629 2632 B-upper_bound
mg 28 30 2633 2635 I-upper_bound
/ 30 31 2635 2636 I-upper_bound
dL 31 33 2636 2638 I-upper_bound
or 34 36 2639 2641 O
> 37 38 2642 2643 O
3.0 38 41 2643 2646 B-lower_bound
x 42 43 2647 2648 I-lower_bound
ULN 44 47 2649 2652 I-lower_bound
for 48 51 2653 2656 O
subjects 52 60 2657 2665 O
with 61 65 2666 2670 O
hereditary 66 76 2671 2681 O
benign 77 83 2682 2688 O
hyperbilirubinemia 84 102 2689 2707 B-treatment

Subjects 0 8 2708 2716 O
with 9 13 2717 2721 O
active 14 20 2722 2728 O
malignancy 21 31 2729 2739 B-cancer
and/or 32 38 2740 2746 O
cancer 39 45 2747 2753 B-cancer
history 46 53 2754 2761 O
that 54 58 2762 2766 O
may 59 62 2767 2770 O
confound 63 71 2771 2779 O
the 72 75 2780 2783 O
assessment 76 86 2784 2794 O
of 87 89 2795 2797 O
the 90 93 2798 2801 O
study 94 99 2802 2807 O
endpoints 100 109 2808 2817 O

The 0 3 2818 2821 O
presence 4 12 2822 2830 O
of 13 15 2831 2833 O
alopecia 16 24 2834 2842 B-chronic_disease
of 25 27 2843 2845 O
any 28 31 2846 2849 O
grade 32 37 2850 2855 O
and 38 41 2856 2859 O
peripheral 42 52 2860 2870 B-chronic_disease
neuropathy 53 63 2871 2881 I-chronic_disease
≤ 64 65 2882 2883 O
Grade 66 71 2884 2889 B-upper_bound
2 72 73 2890 2891 I-upper_bound
without 74 81 2892 2899 O
pain 82 86 2900 2904 O

The 0 3 2905 2908 O
test 4 8 2909 2913 O
must 9 13 2914 2918 O
have 14 18 2919 2923 O
a 19 20 2924 2925 O
sensitivity 21 32 2926 2937 O
of 33 35 2938 2940 O
at 36 38 2941 2943 O
least 39 44 2944 2949 O
50 45 47 2950 2952 B-lower_bound
mIU 48 51 2953 2956 I-lower_bound
/ 51 52 2956 2957 I-lower_bound
mL 52 54 2957 2959 I-lower_bound

Uncontrolled 0 12 2960 2972 O
intercurrent 13 25 2973 2985 O
illness 26 33 2986 2993 O
including 34 43 2994 3003 O
, 43 44 3003 3004 O
but 45 48 3005 3008 O
not 49 52 3009 3012 O
limited 53 60 3013 3020 O
to 61 63 3021 3023 O
, 63 64 3023 3024 O
uncontrolled 65 77 3025 3037 O
infection 78 87 3038 3047 B-chronic_disease
, 87 88 3047 3048 O
disseminated 89 101 3049 3061 B-chronic_disease
intravascular 102 115 3062 3075 I-chronic_disease
coagulation 116 127 3076 3087 I-chronic_disease
( 128 129 3088 3089 I-chronic_disease
DIC 129 132 3089 3092 I-chronic_disease
) 132 133 3092 3093 I-chronic_disease
, 133 134 3093 3094 O
or 135 137 3095 3097 O
psychiatric 138 149 3098 3109 B-chronic_disease
illness 150 157 3110 3117 I-chronic_disease
/ 157 158 3117 3118 I-chronic_disease
social 158 164 3118 3124 I-chronic_disease
situations 165 175 3125 3135 I-chronic_disease
that 176 180 3136 3140 O
would 181 186 3141 3146 O
limit 187 192 3147 3152 O
compliance 193 203 3153 3163 O
with 204 208 3164 3168 O
study 209 214 3169 3174 O
requirements 215 227 3175 3187 O

Uncontrolled 0 12 3188 3200 O
, 12 13 3200 3201 O
clinically 14 24 3202 3212 O
significant 25 36 3213 3224 O
pulmonary 37 46 3225 3234 B-chronic_disease
disease 47 54 3235 3242 I-chronic_disease
( 55 56 3243 3244 O
e.g. 56 60 3244 3248 O
, 60 61 3248 3249 O
chronic 62 69 3250 3257 B-chronic_disease
obstructive 70 81 3258 3269 I-chronic_disease
pulmonary 82 91 3270 3279 I-chronic_disease
disease 92 99 3280 3287 I-chronic_disease
( 100 101 3288 3289 I-chronic_disease
COPD 101 105 3289 3293 I-chronic_disease
) 105 106 3293 3294 I-chronic_disease
, 106 107 3294 3295 O
pulmonary 108 117 3296 3305 B-chronic_disease
hypertension 118 130 3306 3318 I-chronic_disease
) 130 131 3318 3319 O
that 132 136 3320 3324 O
in 137 139 3325 3327 O
the 140 143 3328 3331 O
opinion 144 151 3332 3339 O
of 152 154 3340 3342 O
the 155 158 3343 3346 O
investigator 159 171 3347 3359 O
would 172 177 3360 3365 O
put 178 181 3366 3369 O
the 182 185 3370 3373 O
patient 186 193 3374 3381 O
at 194 196 3382 3384 O
significant 197 208 3385 3396 O
risk 209 213 3397 3401 O
for 214 217 3402 3405 O
pulmonary 218 227 3406 3415 O
complications 228 241 3416 3429 O
during 242 248 3430 3436 O
the 249 252 3437 3440 O
study 253 258 3441 3446 O

an 0 2 3447 3449 O
abnormal 3 11 3450 3458 B-clinical_variable
serum 12 17 3459 3464 I-clinical_variable
FLC 18 21 3465 3468 I-clinical_variable
ratio 22 27 3469 3474 I-clinical_variable
( 28 29 3475 3476 O
< 29 30 3476 3477 O
0.26 30 34 3477 3481 B-upper_bound
or 35 37 3482 3484 O
> 38 39 3485 3486 O
1.65 39 43 3486 3490 B-lower_bound
) 43 44 3490 3491 O

inhaled 0 7 3492 3499 B-treatment
corticosteroids 8 23 3500 3515 I-treatment
are 24 27 3516 3519 O
permitted 28 37 3520 3529 O

